PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
Titel:
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
Auteur:
Guerin, Mathilde Rezai, Keyvan Isambert, Nicolas Campone, Mario Autret, Aurélie Pakradouni, Jihane Provansal, Magali Camerlo, Jacques Sabatier, Renaud Bertucci, François Charafe-Jauffret, Emmanuelle Hervieu, Alice Extra, Jean-Marc Viens, Patrice Lokiec, François Boher, Jean-Marie Gonçalves, Anthony